Alivus Life Sciences Limited (NSE:ALIVUS)
India
· Delayed Price · Currency is INR 1,081.15
+19.50 (1.84%)
At close: Mar 28, 2025, 3:30 PM IST
Alivus Life Sciences Market Cap
Alivus Life Sciences has a market cap or net worth of 132.48 billion as of March 31, 2025. Its market cap has increased by 47.61% in one year.
Market Cap
132.48B
Enterprise Value
128.17B
Revenue
22.74B
Ranking
n/a
PE Ratio
30.09
Stock Price
1,081.15
Market Cap Chart
Since August 6, 2021, Alivus Life Sciences's market cap has increased from 91.71B to 132.48B, an increase of 44.45%. That is a compound annual growth rate of 10.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 132.48B | 9.93% |
| Dec 31, 2024 | 120.50B | 49.68% |
| Dec 29, 2023 | 80.51B | 56.38% |
| Dec 30, 2022 | 51.48B | -33.42% |
| Dec 31, 2021 | 77.32B | -15.69% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,162.13B |
| Divi's Laboratories | 1,533.20B |
| Cipla | 1,164.75B |
| Mankind Pharma | 1,000.40B |
| Apollo Hospitals Enterprise | 951.31B |
| Zydus Lifesciences | 891.93B |
| Aurobindo Pharma | 674.02B |
| Alkem Laboratories | 583.68B |